V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220021298 | 220017291 | 1.56 | 7.5 | Disease modification (D) | 2016-10-22 | 2016-12-03 | NB HRNBL-1 COJEC Ind COURSE C | 02 | N | 220023478 | NOT MATCHED |
| 220021299 | 220006188 | 1.88 | 52.5 | Palliative (P) | null | 2018-10-19 | Hydroxycarbamide | N | null | 220023489 | HYDROXYCARBAMIDE |
| 220021300 | 220006215 | 1.78 | 67.2 | Curative (C) | null | 2016-05-17 | Cytarabine Low Dose | Y | N | 220023606 | CYTARABINE |
| 220021301 | 220013346 | 0 | 0 | Disease modification (D) | 2016-10-22 | 2016-10-22 | Hydroxycarbamide | 02 | null | 220023640 | HYDROXYCARBAMIDE |
| 220021302 | 220006229 | 1.53 | 52 | Radical (R) | 2014-05-16 | 2014-06-23 | AML MyeChild 01 B Cytarabine/Daunoxome | 02 | null | 220023646 | NOT MATCHED |
| 220021303 | 220006241 | 1.59 | null | Disease modification (D) | 2016-09-10 | 2017-01-13 | Hydroxycarbamide | Y | N | 220023676 | HYDROXYCARBAMIDE |
| 220021304 | 220006248 | 1.66 | null | Palliative (P) | 2016-04-01 | 2017-06-25 | Cytarabine Low Dose | Y | N | 220023701 | CYTARABINE |
| 220021305 | 220006258 | null | 65.1 | Curative (C) | null | 2014-04-03 | CYTARABINE | N | N | 220023737 | CYTARABINE |
| 220021306 | 220019492 | 1.6 | 52 | Disease modification (D) | 2014-09-11 | 2014-09-11 | Hydroxycarbamide | N | N | 220023739 | HYDROXYCARBAMIDE |
| 220021307 | 220006263 | 0 | 0 | Palliative (P) | 2015-06-12 | 2015-07-24 | Hydroxycarbamide | N | N | 220023759 | HYDROXYCARBAMIDE |
| 220021308 | 220019493 | 0 | 0 | Disease modification (D) | 2013-08-03 | 2013-09-28 | Hydroxycarbamide | 02 | N | 220023793 | HYDROXYCARBAMIDE |
| 220021309 | 220006277 | null | 24.8 | Curative (C) | 2014-11-13 | 2015-02-05 | null | null | null | 220023811 | NOT MATCHED |
| 220021310 | 220006282 | 0 | 70.4 | Palliative (P) | 2018-03-02 | 2018-03-02 | Hydroxycarbamide | 2 | N | 220023821 | HYDROXYCARBAMIDE |
| 220021312 | 220006296 | 1.05 | 73.4 | Disease modification (D) | 2017-12-21 | 2019-05-20 | Hydroxycarbamide | N | N | 220023866 | HYDROXYCARBAMIDE |
| 220021313 | 220006302 | 0 | 7.6 | Curative (C) | 2017-06-17 | 2017-08-29 | AML MyeChild 01 A Mitozantrone/Cytarabine | Y | N | 220023877 | NOT MATCHED |
| 220021314 | 220006317 | 1.65 | 76.4 | Curative (C) | 2017-05-17 | 2017-05-27 | AML MyeChild 01 B Cytarabine/Daunoxome + GO | N | Y | 220023938 | NOT MATCHED |
| 220021315 | 220013424 | 1.6 | null | Palliative (P) | 2018-04-21 | 2018-04-26 | ALL Ph+ve Dasatinib Continuation | 2 | N | 220024004 | NOT MATCHED |
| 220021316 | 220006336 | null | 90 | Curative (C) | 2017-10-05 | 2017-10-05 | Cytarabine Low Dose | N | null | 220024041 | CYTARABINE |
| 220021317 | 220006340 | 1.62 | null | Disease modification (D) | null | 2017-02-25 | CYTARABINE | N | N | 220024098 | CYTARABINE |
| 220021319 | 220017348 | 1.71 | 101 | Palliative (P) | 2017-09-27 | 2017-09-27 | Hydroxycarbamide | 2 | N | 220024163 | HYDROXYCARBAMIDE |
| 220021320 | 220006369 | null | 81.6 | Disease modification (D) | 2014-09-25 | 2014-09-25 | Cytarabine Low Dose | 02 | N | 220024229 | CYTARABINE |
| 220021321 | 220006378 | 1.74 | null | Palliative (P) | 2016-08-26 | 2016-08-27 | Hydroxycarbamide | 2 | N | 220024262 | HYDROXYCARBAMIDE |
| 220021322 | 220006387 | 1.49 | null | Disease modification (D) | null | 2015-07-23 | Cytarabine Low Dose | 99 | N | 220024304 | CYTARABINE |
| 220021323 | 220006393 | 0 | 61 | Curative (C) | null | 2017-05-12 | AML MyeChild 01 FLA | 2 | N | 220024319 | NOT MATCHED |
| 220021324 | 220021445 | null | 13.5 | Curative (C) | 2015-12-29 | 2015-12-29 | AML MyeChild 01 FLA-Idarubicin | 02 | N | 220024326 | NOT MATCHED |
| 220021325 | 220006407 | 1.68 | null | Curative (C) | 2015-06-17 | 2015-08-27 | AML MyeChild 01 FLA-Idarubicin | N | N | 220024353 | NOT MATCHED |
| 220021326 | 220017362 | null | 83.3 | Palliative (P) | 2015-09-21 | 2015-09-21 | Cytarabine Low Dose | N | N | 220024357 | CYTARABINE |
| 220021328 | 220013486 | null | 115 | Palliative (P) | 2014-03-01 | 2014-03-02 | CYTARABINE | N | N | 220024416 | CYTARABINE |
| 220021329 | 220021448 | 0 | 0 | Disease modification (D) | 2018-12-14 | 2018-12-15 | Hydroxycarbamide | 2 | N | 220024432 | HYDROXYCARBAMIDE |
| 220021330 | 220013492 | 0 | null | Disease modification (D) | 2018-01-03 | 2018-01-03 | Hydroxycarbamide | 02 | N | 220024442 | HYDROXYCARBAMIDE |
| 220021332 | 220013502 | 1.8 | 66 | Palliative (P) | 2014-08-06 | 2014-09-15 | CYTARABINE | 02 | N | 220024482 | CYTARABINE |
| 220021333 | 220006445 | 1.6 | null | Disease modification (D) | 2015-11-28 | 2015-12-02 | Hydroxycarbamide | null | null | 220024501 | HYDROXYCARBAMIDE |
| 220021334 | 220006455 | 1.76 | 74.9 | Disease modification (D) | 2018-04-06 | 2018-04-07 | Hydroxycarbamide | N | N | 220024528 | HYDROXYCARBAMIDE |
| 220021335 | 220006473 | 0 | 25.2 | Disease modification (D) | 2017-03-12 | 2017-04-14 | FLUDARABINE + THIOTEPA + TREOSULFAN | 02 | N | 220024615 | NOT MATCHED |
| 220021336 | 220006486 | 1.67 | null | Disease modification (D) | 2014-05-08 | 2014-05-22 | Cytarabine Low Dose | 02 | null | 220024673 | CYTARABINE |
| 220021337 | 220013541 | 1.54 | null | Curative (C) | 2014-05-23 | 2014-08-02 | Hydroxycarbamide | N | N | 220024689 | HYDROXYCARBAMIDE |
| 220021338 | 220022253 | 1.67 | 61.9 | Palliative (P) | 2019-01-02 | 2019-03-19 | AML MyeChild 01 HD AraC | 02 | N | 220024708 | NOT MATCHED |
| 220021339 | 220013549 | 1.67 | null | Palliative (P) | 2017-01-21 | 2017-01-23 | Hydroxycarbamide | 02 | N | 220024764 | HYDROXYCARBAMIDE |
| 220021341 | 220006518 | null | 71 | Adjuvant (A) | 2013-04-16 | 2013-04-16 | Hydroxycarbamide | N | null | 220024810 | HYDROXYCARBAMIDE |
| 220021342 | 220006519 | null | 78 | Disease modification (D) | 2017-04-21 | 2017-04-21 | Hydroxycarbamide | N | N | 220024820 | HYDROXYCARBAMIDE |
| 220021343 | 220022298 | 1.54 | 70.9 | Disease modification (D) | 2015-06-14 | 2015-10-11 | Hydroxycarbamide | 2 | N | 220024847 | HYDROXYCARBAMIDE |
| 220021344 | 220006530 | null | null | Palliative (P) | null | 2016-09-07 | Cytarabine Low Dose | null | null | 220024903 | CYTARABINE |
| 220021347 | 220006554 | 1.85 | 0 | Palliative (P) | 2013-11-11 | 2014-05-02 | Hydroxycarbamide | N | N | 220025054 | HYDROXYCARBAMIDE |
| 220021348 | 220006558 | null | 57.9 | Disease modification (D) | 2016-12-05 | 2017-02-24 | Hydroxycarbamide | null | N | 220025077 | HYDROXYCARBAMIDE |
| 220021349 | 220006568 | 0 | null | Curative (C) | 2016-05-30 | 2016-07-09 | AML MyeChild 01 A Mitozantrone/Cytarabine | N | N | 220025121 | NOT MATCHED |
| 220021350 | 220006578 | null | null | Palliative (P) | 2016-12-21 | 2016-12-22 | Cytarabine Low Dose | null | null | 220025174 | CYTARABINE |
| 220021351 | 220006583 | null | 57.1 | Palliative (P) | 2017-07-11 | 2017-07-14 | Hydroxycarbamide | 1 | N | 220025180 | HYDROXYCARBAMIDE |
| 220021352 | 220013613 | null | 89.3 | null | 2016-05-08 | 2016-07-12 | AML18 PILOT TRIAL | Y | N | 220025353 | PILOT TRIAL |
| 220021353 | 220019557 | 1.49 | 98.9 | Curative (C) | 2016-01-05 | 2016-04-01 | AML 18 TRIAL | Y | N | 220025361 | AML18 TRIAL |
| 220021354 | 220006637 | null | 51.5 | Adjuvant (A) | 2015-12-28 | 2016-01-01 | AML18 PILOT TRIAL | Y | N | 220025425 | PILOT TRIAL |